Publication | Closed Access

Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer

NanomedicineEngineeringPolymer-drug ConjugateMedicinePharmacologyDoxorubicin ChemotherapyHuman Breast CancerBreast CancerNano-drug DeliveryTumor TargetingBiomedical EngineeringBiopolymeric NanocarrierOncology